Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Clinical trial NCT02143726 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02143726
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-09
- Primary completion
- 2021-01-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.